Michael H Gelb Selected Research

p21(ras) farnesyl-protein transferase (protein farnesyltransferase)

1/2008	2-Oxo-tetrahydro-1,8-naphthyridines as selective inhibitors of malarial protein farnesyltransferase and as anti-malarials.
2/2006	Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation.
8/2005	The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas disease.
7/2005	Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.
6/2005	Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.
8/2002	Isothiazole dioxides: synthesis and inhibition of Trypanosoma brucei protein farnesyltransferase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael H Gelb Research Topics

Disease

24	Inflammation (Inflammations) 01/2022 - 05/2002
14	Neoplasms (Cancer) 01/2016 - 10/2003
13	Asthma (Bronchial Asthma) 01/2021 - 04/2007
10	Malaria 06/2015 - 02/2003
9	Mucopolysaccharidoses 03/2020 - 01/2011
9	African Trypanosomiasis (Nagana) 02/2020 - 08/2002
9	Chagas Disease (American Trypanosomiasis) 12/2013 - 12/2003
8	Globoid Cell Leukodystrophy (Krabbe Disease) 01/2022 - 03/2004
8	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2021 - 01/2007
7	Mucopolysaccharidosis I (Hurler Syndrome) 01/2022 - 12/2008
7	Glycogen Storage Disease Type II (Pompe's Disease) 01/2022 - 10/2004
6	Respiratory Hypersensitivity 01/2021 - 01/2013
5	Mucopolysaccharidosis II (Hunter Syndrome) 01/2022 - 01/2007
4	Mucopolysaccharidosis IV (Morquio Syndrome) 03/2020 - 10/2010
4	Fabry Disease (Fabry's Disease) 01/2020 - 10/2011
4	Infections 10/2011 - 02/2003
4	Atherosclerosis 10/2010 - 01/2008
3	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2021 - 06/2014
3	Mucopolysaccharidosis III (Sanfilippo Syndrome) 03/2020 - 03/2012
3	Porphyrias (Porphyria) 08/2010 - 04/2008
3	Parasitic Diseases (Parasitic Disease) 02/2009 - 02/2003
3	Progeria (Hutchinson Gilford Syndrome) 10/2005 - 07/2005
2	Cholesterol Ester Storage Disease 12/2020 - 01/2018
2	Wolman Disease (Wolman's Disease) 12/2020 - 01/2018
2	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2020 - 08/2014
2	Arthritis (Polyarthritis) 01/2019 - 05/2010
2	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 10/2018 - 08/2014
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016 - 01/2005
2	Metaplasia 08/2011 - 04/2007
2	Rheumatoid Arthritis 01/2011 - 05/2010
2	Colonic Neoplasms (Colon Cancer) 10/2009 - 09/2007
2	Carcinogenesis 10/2009 - 09/2007
2	Neoplasm Metastasis (Metastasis) 03/2009 - 10/2004
2	Prostatic Neoplasms (Prostate Cancer) 12/2008 - 10/2004
2	Bacterial Infections (Bacterial Infection) 01/2008 - 03/2005
2	Atopic Dermatitis (Atopic Eczema) 05/2002 - 04/2002
1	Cerebrotendinous Xanthomatosis 10/2020

Drug/Important Bio-Agent (IBA)

49	EnzymesIBA 01/2022 - 01/2003
31	Secretory Phospholipases A2IBA 01/2020 - 07/2003
14	Pharmaceutical PreparationsIBA 02/2020 - 02/2003
13	Phospholipases (Phospholipase)IBA 01/2022 - 08/2002
13	EicosanoidsIBA 01/2021 - 10/2004
13	Group X Phospholipases A2IBA 01/2020 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2017
6	CytokinesIBA 01/2020 - 04/2007
6	Arachidonic Acid (Vitamin F)IBA 05/2013 - 10/2004
6	p21(ras) farnesyl-protein transferase (protein farnesyltransferase)IBA 01/2008 - 08/2002
5	Iduronidase (alpha-L-Iduronidase)IBA 01/2022 - 12/2008
5	AllergensIBA 01/2020 - 04/2007
5	tipifarnib (R115777)IBA 01/2019 - 08/2005
5	Phospholipases A2 (Phospholipase A2)IBA 11/2017 - 10/2009
5	AcidsIBA 07/2017 - 10/2004
5	LipidsIBA 01/2016 - 10/2009
5	Group II Phospholipases A2IBA 01/2016 - 04/2002
4	GlycosaminoglycansIBA 01/2022 - 01/2020
4	Psychosine (Galactosylsphingosine)IBA 01/2022 - 01/2020
4	GalactosylceramidaseIBA 01/2022 - 08/2017
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 07/2003
3	GalactosidasesIBA 01/2021 - 10/2011
3	Sulfoglycosphingolipids (Sulfatides)IBA 01/2021 - 06/2014
3	GlucosidasesIBA 07/2017 - 08/2013
3	N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA 12/2015 - 11/2010
3	LipopolysaccharidesIBA 03/2015 - 04/2002
3	Heme (Haem)IBA 08/2010 - 04/2008
3	TransferasesIBA 10/2005 - 02/2003
2	Galactosylceramides (Galactocerebrosides)IBA 01/2022 - 01/2020
2	Surface-Active Agents (Surfactants)IBA 01/2021 - 07/2003
2	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2021 - 01/2016
2	Sterol Esterase (Hormone-Sensitive Lipase)IBA 12/2020 - 01/2018
2	CholesterolIBA 01/2019 - 07/2011
2	AntigensIBA 11/2017 - 12/2016
2	LysophospholipidsIBA 11/2017 - 10/2010
2	Antiparasitic Agents (Antiparasitics)IBA 01/2017 - 02/2014
2	OvalbuminIBA 12/2016 - 04/2007
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2015 - 10/2004
2	varespladibIBA 03/2015 - 11/2009
2	Lipase (Acid Lipase)FDA Link 07/2014 - 05/2013
2	CarboxypeptidasesIBA 05/2014 - 01/2010
2	Tryptases (Tryptase)IBA 05/2014 - 01/2010
2	SterolsIBA 12/2013 - 09/2012
2	Group V Phospholipases A2IBA 01/2013 - 05/2010
2	Protein Glutamine gamma Glutamyltransferase 2IBA 12/2012 - 01/2010
2	posaconazole FDA Link 09/2012 - 06/2009
2	SulfatasesIBA 01/2011 - 11/2010
2	LanosterolIBA 05/2010 - 06/2009
2	Phospholipases AIBA 05/2010 - 07/2003
2	Group IV Phospholipases A2IBA 12/2008 - 03/2005
2	AndrogensIBA 12/2008 - 10/2004
2	Farnesyltranstransferase (Farnesyltransferase)IBA 09/2008 - 02/2008
2	LeukotrienesIBA 12/2007 - 04/2002
2	Acarbose FDA LinkGeneric 04/2006 - 10/2004
2	alpha-Glucosidases (Acid Maltase)IBA 04/2006 - 10/2004
2	prelamin AIBA 09/2005 - 07/2005
1	Triglycerides (Triacylglycerol)IBA 12/2020
1	Cholesterol Esters (Cholesteryl Esters)IBA 12/2020
1	Sebelipase alfaIBA 12/2020
1	Cholestanetriol 26-Monooxygenase (Cholestanetriol 26 Monooxygenase)IBA 10/2020

Therapy/Procedure

13	Therapeutics 12/2020 - 02/2003
2	Enzyme Replacement Therapy 12/2020 - 01/2018